ATLANTA, December 9, 2012 – The Cutaneous Lymphoma Foundation (CLF), selected Giorgia Saporiti, MD to be the recipient of their 2012 Young Investigator’s Award. Dr. Saporiti, pictured on the right with CLF board member Dr. Pierluigi Porcu, received the award on Sunday December 9, 2012, at a special reception during the American Society of Hematology annual meeting in Atlanta, Ga.
“We are thrilled to be able to present this award to such a deserving recipient,” said Susan Thornton, CEO, Cutaneous Lymphoma Foundation. “Dr. Saporiti is an exceptional young clinician-scientist, with a deep knowledge of the clinical and basic aspects of haematological cancers and devotion to her work and patients.”
During the ASH congress, Dr Saporiti presented a research abstract entitled “Analysis of Chromosomal Alterations by Array-Based Comparative Genomic Hybridization in 25 Patients with Sézary Syndrome” (http://tinyurl.com/cks6hd3) on Sunday, December 9, 2012, 6:00 PM-8:00 PM.
“Dr. Saporiti’s focus on the study of the basic biology and genetics of Sezary Syndrome, distinguished her candidacy for this award,” said Pierluigi Porcu, MD, Associate Professor of Internal Medicine, Division of Hematology, Comprehensive Cancer Center, The Ohio State University, and CLF Board Member. “We are impressed by her serious focus in laboratory research, as well as her interest in translating her research into better patient care.”
In 2004, Dr. Saporiti began her studies at the University of Milan-Bicocca,Medical School. After graduation, she attended the four-year course of Specialization in Hematology, acquiring broad and deep expertise in the outpatient and inpatient care of patients with hematologic diseases. . In 2009 she enrolled in the Experimental Hematology PhD program of the University of Milan-Fondazione Ca’ Granda, with a project centered on molecular characterization of patients affected by Sézary Syndrome in collaboration with her mentor, Dr. Emilio Berti, Director of the Center for Research in Experimental Dermatology and Cutaneous Oncology, of the University of Milan-Bicocca. Dr. Saporiti interest includes the use of allogeneic stem cell transplantation for patients with advanced-phase mycosis fungoides and Sézary Syndrome.
Dr. Saporiti has been involved in numerous collaborative research projects, developing special knowledge of clinical data management and had established herself as an individual with serious research interests, having authored or co-authored more than 25 scientific papers and abstracts.. She has also shown a dedication to help those in need by volunteering for medical work in India.
About Cutaneous Lymphomas
Cutaneous lymphomas are cancers of lymphocytes (white blood cells) that primarily involve the skin. Classification is based on lymphocyte type: B-lymphocytes (B-cell) or T-lymphocytes (T-cell). Cutaneous T-cell lymphoma (CTCL) is the most common type of cutaneous lymphoma that typically presents with red, scaly patches or thickened plaques of skin that often mimic eczema or chronic dermatitis. Progression from limited skin involvement is variable and may be accompanied by tumor formation, ulceration and exfoliation, complicated by itching and infections. Advanced stages are defined by involvement of lymph nodes, peripheral blood, and internal organs.
Cutaneous lymphomas affect tens of thousands of individuals worldwide. It is estimated that more than 30,000 in the United States and Canada have been diagnosed with this disease. The incidence has been increasing in the US with approximately 3,000 new cases being diagnosed annually.
About the Cutaneous Lymphoma Foundation
The Cutaneous Lymphoma Foundation is an independent, nonprofit patient advocacy organization whose mission is to support every person with cutaneous lymphoma by promoting awareness and education, advancing patient care, and facilitating research. The Cutaneous Lymphoma Foundation was founded in 1998 and it is the only organization worldwide that offers comprehensive programs and services that provide information, resources and support to people affected by cutaneous lymphoma. The Cutaneous Lymphoma Foundation currently serves people from around the world who access our organization for assistance and support. For more information, please visit www.clfoundation.org or contact the Foundation at (248) 644-9014 or send an email to .
This is an automatic translation service and therefore the
Cutaneous Lymphoma Foundation is not responsible
for any potential translation inaccuracies.